• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • Navigate Novartis
    • Patients
    • Healthcare Professionals
    • Media
    • Investors
    • Partners
    • ESG
    • Job Seekers
    • Clinical Trials
  • Coronavirus
  • Global
    • Novartis site directory
Novartis logo: a global healthcare company
  • Our Company
    • Our Leadership
      • Board of Directors
      • Executive Committee of Novartis
    • Our Approach
      • Strategy
      • Corporate Responsibility
      • Diversity & Inclusion
      • Partnering
      • People and Culture
    • Our Business
      • Global Product Portfolio
      • Innovative Medicines
      • Novartis Pharmaceuticals
      • Novartis Gene Therapies
      • Novartis Oncology
      • Sandoz
    • Media
      • Newsroom
      • News Archive
      • Multimedia Resources
      • Subscribe to Updates
    • Investors
      • Event Calendar
      • Financial Data
      • Share Data & Analysis
      • Shareholder Information
      • Environmental, Social & Governance
  • Our Focus
    • Disease Areas
      • Cancer
      • Cardiovascular, Renal & Metabolism
      • Immunology & Dermatology
      • Ophthalmology
      • Neuroscience
      • Respiratory
    • Platforms and Technology
      • Data and Digital
      • Cell & Gene Therapy
    • Novartis Stories
      • Discovery
      • From Our Labs
      • Access to Healthcare
      • Patient Perspectives
      • People and Culture
      • Live Magazine
  • Our Impact
    • Building Trust with Society
      • Corporate Responsibility
      • Ethical Standards
      • Access
      • Environmental Sustainability
    • Global Health
      • Malaria
      • Sickle Cell Disease
      • Chagas disease
      • Leprosy
      • Novartis Foundation
    • ESG Performance and Reporting
      • Materiality
      • Environment, Social and Governance
      • Transparency and Disclosures
      • Positions on Key Topics
      • Statements on Key Issues
  • Our Science
    • Research & Early Development
      • Novartis Institutes for BioMedical Research
      • Research Disease Areas
      • Postdoc Program
      • Open Source Science
    • Drug Development at Novartis
      • Novartis Pipeline
      • Clinical Trials
      • Translational Medicine
      • Global Product Portfolio
    • Science Stories
      • Discovery
      • From Our Labs
  • Careers
    • Your Career
      • Global Career Search
      • Teams and Skills
      • Gene Therapies Careers
    • Working at Novartis
      • Diversity & Inclusion
      • Corporate Responsibility
    • Career Programs
      • Our Career Programs
      • Students and Scholars
      • Novartis Quantitative Sciences Hackathon
Search
Putting patients first
  • TwitterTweet
  • FacebookShare
  • Share
    • Twitter
    • Facebook
    • LinkedIn
    • Email
    • Whatsapp
  • Jump to Comments
Stories/Patient Perspectives

Putting patients first

Chinweike Ukomadu thinks that notions about clinicians turning their backs on patients when transitioning to industry are outdated. 

Sep 08, 2015

Doctors who take industry jobs can still be viewed with suspicion by some of their dyed-in-the-wool medical colleagues. They are selling out, abandoning patients – at least that’s the accusation leveled at them. Is this an outdated notion? Clinician and former academic Chinweike Ukomadu thinks so.

“One thing a lot of people don’t know about moving from academia to industry is that a lot of physicians continue to have contact with patients,” says Ukomadu, who early last year joined the Novartis Institutes for BioMedical Research (NIBR) as a translational medicine expert after more than 20 years as a physician and academic researcher at Brigham and Women’s Hospital (BWH) in Boston.  

The Yale University MD-PhD still sees patients several times a month at BWH. He says they understand and support his recent change of career direction. “Before I left Brigham, I met most of my patients in person to tell them I had this opportunity to come to Novartis. They all said the same thing: ‘We are going to miss you, but we hope you can discover something that can help us.’ Patients get it; they know medicines don’t just materialize out of thin air.”

In his new role, Ukomadu shapes NIBR’s early clinical trials of potential new medicines for liver disease. He says his move into drug development gives him the chance to make an even bigger difference for patients than was possible in clinical academia.

“It became obvious to me that I was not really having the impact that I needed as far as patients were concerned,” he recalls. “This opportunity came up where I actually do have a goal of discovering something and making a medicine that will reach hundreds of thousands of people. That's the fulfillment of something I've always wanted to do.”

Tags: 
Novartis Institutes for BioMedical Research, Clinical Research, Careers, Clinical Trials, Clinical Science
    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
      • Whatsapp
    • Jump to Comments
  • Print
  • Save

Novartis Stories

View all

A woman, accompanied by her caregiver, shares her experiences with a doctor.
Patient Perspectives

Turning the sound up on patient voices in lung cancer research and development

Chinese family embracing exercise and the outdoors
Patient Perspectives

AI Nurse evolving for health failure patients in China

Patient living with chronic myeloid leukemia advocates for herself
Patient Perspectives

Speaking Up in CML

You are here

  1. Home ›
  2. Stories ›
  3. Patient Perspectives

Novartis Global

  • Navigate Novartis

    • Patients & Caregivers
    • Healthcare Professionals
    • Investors
    • Media
    • Society & ESG
    • Partners
  • Contact Us

    • Global Contacts
    • Office Locations
    • For Investors
    • For Media
  • About Novartis

    • Our Company
    • Our Focus
    • Our Impact
    • Our Science
    • Our Stories
  • Our Portfolio

    • Global Product Portfolio
    • Global Clinical Pipeline
  • Careers

    • Career Search

Connect with Novartis

  • twitter
  • linkedin
  • youtube
  • facebook
  • instagram
Novartis Site Directory
© 2021 Novartis AG
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Site Map
  • Cookie Settings

This site is intended for a global audience.